Ganga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve the Audited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ganga Pharmaceuticals has informed BSE that its Board of Directors meeting is scheduled for May 21, 2026, to consider and approve the Audited Financial Results for the half year and financial year ended March 31, 2026. The company has closed its trading window from April 01, 2026, for all Designated Persons under its Insider Trading Code, and it will reopen 48 hours after the results are declared. This is a routine regulatory intimation under SEBI Listing Regulations. No specific financial details, prior period comparisons, or auditor remarks are included in this filing.
This is a standard pre-results announcement with no immediate shareholder action required. The outcome and actual financial numbers will be disclosed after the May 21, 2026 meeting.